COSTING AND AVAILABILITY OF DRUG THERAPY AND DIAGNOSTIC ASSAYS FOR CRYPTOCOCCAL INFECTION. Iman Wanis , Cushla Coffey, Shaffiq Essajee , and Philippa Easterbrook World Health Organization, HIV Department (ATC) Geneva, Switzerland July 2011. CRYPTOCOCCAL DRUGS AND DIAGNOSTICS.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
COSTING AND AVAILABILITY OF DRUG THERAPY AND DIAGNOSTIC ASSAYS FOR CRYPTOCOCCAL INFECTION
ImanWanis, Cushla Coffey, ShaffiqEssajee,
and Philippa Easterbrook
World Health Organization, HIV Department (ATC)
Progress of the projects
Performance of suppliers
Achievement of key objectives
* Source: A meeting with UNITAID/CHAI Pediatrics ARVs Project Coordinator
1. International Drug Price Indicator Guide (IDPI)
2. Global Price Reporting Mechanism (GPRM) http://www.who.int/hiv/amds/gprm/en/
4. Telephone Country Survey: 8 HIV clinicians, 1 laboratory director, 1 clinical microbiologist, 1 pharmacist, NAP director and 1 Information Management advisor.
Uganda (2009) $2.6/50mg ampho
Burundi (2009) $2.6/50mg ampho
Angola (2008) $12.31/50mg ampho
Malawi (2009) $2.48/50mg ampho
LA= CRAG Latex Agglutination LFA= CRAG Lateral Flow Assay SCMS= Supply Chain Management System